SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001599298-20-000033
Filing Date
2020-08-19
Accepted
2020-08-19 16:04:18
Documents
2
Period of Report
2020-08-19

Document Format Files

Seq Description Document Type Size
1 6-K august20206-kxgm.htm 6-K 21024
2 EX-99.1 pressreleaseaugust1920.htm EX-99.1 11970
  Complete submission text file 0001599298-20-000033.txt   34116
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 201117124
SIC: 2834 Pharmaceutical Preparations